BD (Becton, Dickinson and Company), a leading global medical technology company, announced today that it has acquired GenCell Biosystems, a privately-held Irish biotech company.
By Kathleen Gallagher, Milwaukee Journal Sentinel Madison-based Exact Sciences Corp.’s noninvasive, colon cancer screening test is now being covered for Medicare patients, the Centers for Medicare & Medicaid Services said late Thursday. The decision, which was widely expected, means that Medicare patients will now be able to, under the supervision of their doctors, have their […]
WisBusiness.com For Mitchell Gold, cancer is personal. That’s because his mother died from breast cancer when he was 4 and she was just 26. His grandmother also died of the disease at age 31. They both had — along with his sister — a mutation of the tumor suppressor genes known as BRCA that produces […]
Madworks Coworking’s accelerator program on the University of Wisconsin-Madison campus, announces the second class of companies to begin the program this fall.
SnowShoe has been selected as one of nine startups to vie for a $100,000 investment from AOL co-founder Steve Case, during his Rise of the Rest tour stop in Madison. SnowShoe makes plastic widgets that conduct electricity, sending current from the user’s body to a smartphone or tablet touchscreen for two-factor identification. Rise of the Rest […]
Exact Sciences Corp. today announced that Group Health Cooperative will be the first health plan in Wisconsin to offer Cologuard® to its patients.
URP is pleased to welcome PSC Biotech to the Park. The California-based company, which specializes in making cancer-fighting drugs, will move into the former Mentor Biologics building and plans to hire over 100 positions. Drug production is slated to begin in 2015.
Madworks Coworking’s accelerator program, “Madworks at Campus” is offering grants of up to $4,000 for early stage startups to participate in a high energy 10-week lean startup class that provides structure and mentoring, helping these new businesses determine their viability in the marketplace.
Apply to pitch your company to the most active investors in the Midwest at the annual Wisconsin Early Stage Symposium!
Imbed Biosciences Inc., a Madison company with a novel biomaterials platform for wound dressings and surgical implants, has raised $683,000 of a planned $1 million funding round, according to filings with federal securities regulators.